BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19565921)

  • 21. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
    Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
    Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.
    Okada H; Attanucci J; Tahara H; Pollack IF; Bozik ME; Chambers WH; Lotze MT
    Cancer Gene Ther; 2000 Mar; 7(3):486-94. PubMed ID: 10766355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
    Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy with GM-CSF, interleukin-4 and herpes simplex virus thymidine kinase shows strong antitumor effect on lung cancer.
    Park KH; Kim G; Jang SH; Kim CH; Kwon SY; Yoo CG; Kim YW; Kwon HC; Kim CM; Han SK; Shim YS; Lee CT
    Anticancer Res; 2003; 23(2B):1559-64. PubMed ID: 12828142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell transduction and suicide with an enhanced mutant thymidine kinase.
    Qasim W; Thrasher AJ; Buddle J; Kinnon C; Black ME; Gaspar HB
    Gene Ther; 2002 Jun; 9(12):824-7. PubMed ID: 12040465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
    Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
    Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
    Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vesicular stomatitis virus G-protein retrovector mediated a herpes simplex virus thymidine kinase gene transduction and expression in the human retinal pigment epithelial cells].
    Wang F; Wang HW; Lu DR; Xue JL; Zhang X
    Zhonghua Yan Ke Za Zhi; 2003 Apr; 39(4):201-5. PubMed ID: 12882696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21.
    Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T
    Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
    Hasegawa H; Shimada M; Yonemitsu Y; Utsunomiya T; Gion T; Kaneda Y; Sugimachi K
    Cancer Gene Ther; 2001 Apr; 8(4):252-8. PubMed ID: 11393277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
    Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
    Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total vascular exclusion of the liver enhances the efficacy of retroviral-mediated associated thymidine kinase and interleukin-2 genes transfer against multiple hepatic tumors in rats.
    Alves A; Charre L; Panis Y; Cardoso J; Fabre M; Brisson E; Houssin D; Soubrane O; Klatzmann D
    Surgery; 2003 Jun; 133(6):669-77. PubMed ID: 12796736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y; Zhang X; Hui H
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J; Ma L; Wei L
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
    J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng ; An W; Dai J
    Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.